Literature DB >> 2944385

Lower genital tract infection with Chlamydia trachomatis and Neisseria gonorrhoeae in Icelandic women with salpingitis.

S S Magnússon, T Oskarsson, R T Geirsson, B Sveinsson, O Steingrímsson, H Thorarinsson.   

Abstract

In a study of 225 women with acute salpingitis verified by laparoscopy or laparotomy we investigated the prevalence of gonococcal and chlamydial infection in the lower genital tract. Neisseria gonorrhoeae was isolated from 18.9% of the women and Chlamydia trachomatis from 38.5%. Women with positive cultures were significantly younger (p less than 0.01) than those with negative cultures. A trend toward more severe inflammatory changes of the tubes was found in women with positive cultures compared with those with negative cultures. The majority of women with positive cultures stated they had only one sexual partner during the preceding 6 months. Single women had more partners (mean 1.9) than those cohabiting (mean 1.2). The ratio of single/multiple partners for women with Chlamydia was 2.5:1, and for those with gonorrhea 1:1 (p less than 0.05). Of the men, 60% could be examined and about 50% had positive cultures. Microbiologic investigation of both partners is necessary in order to prevent reinfection of the woman.

Entities:  

Mesh:

Year:  1986        PMID: 2944385     DOI: 10.1016/0002-9378(86)90287-5

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  Acute salpingitis.

Authors:  S L Stanton
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-12

2.  Endocervical Chlamydia trachomatis infection in Canadian adolescents.

Authors:  E G Hughes; J Mowatt; J E Spence
Journal:  CMAJ       Date:  1989-02-01       Impact factor: 8.262

3.  Chlamydia trachomatis infection in primary unexplained infertility.

Authors:  G Gorini; F Milano; P Olliaro; A Regazzetti; E G Rondanelli
Journal:  Eur J Epidemiol       Date:  1990-09       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.